1. Pharmacokinetic effects of antidrug antibodies occurring in healthy subjects after a single dose of intravenous infliximab;Ehrenpreis;Drugs in R&D,2017
2. Committee for medicinal products for human use, guideline on bioanalytical method validation;EMA/CHMP/EWP,2011
3. Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: Results from phase III studies;Kimball;British Journal of Dermatology,2020
4. Protein engineering of DAB-IL-2 fusion toxins to increase biologic potency;Kiyokawa;Annals of the New York Academy of Sciences,1991
5. Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2;LeMaistre;Blood,1998